PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medizinische Klinik und Poliklinik I, Ludwig Maximilian University Hospital Munich, Munich, Germany.\', \'Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig Maximilian University Munich, Planegg-Martinsried, Germany.\', \'Munich Heart Alliance, German Centre for Cardiovascular Research, Munich, Germany.\', \'Department of Proteomics and Signal Transduction, Max Plank Institute of Biochemistry, Planegg-Martinsried, Germany.\', \'Core Facility Bioinformatics, Biomedical Center, Ludwig Maximilian University Munich, Planegg-Martinsried, Germany.\', \'Cardiopathology Department, Institute for Pathology and Neuropathology, Tübingen University Hospital, Tübingen, Germany.\', \'Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamacardio.2021.5133
?:hasPublicationType
?:journal
  • JAMA cardiology
is ?:pmid of
?:pmid
?:pmid
  • 34910083
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.551
?:rankingScore_hIndex
  • 18
is ?:relation_isRelatedTo_publication of
?:title
  • Association of Complement and MAPK Activation With SARS-CoV-2-Associated Myocardial Inflammation.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all